Epigenetic inactivation of calcium-sensing receptor in colorectal carcinogenesis

Keiichi Hizaki, Hiroyuki Yamamoto, Hiroaki Taniguchi, Yasushi Adachi, Mayumi Nakazawa, Tokuma Tanuma, Norihiro Kato, Yasutaka Sukawa, Jose V. Sanchez, Hiromu Suzuki, Shigeru Sasaki, Kohzoh Imai, Yasuhisa Shinomura

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Ca2+ is a chemopreventive agent for colon cancer. Ion transport systems are often altered in human cancer. The aim of this study was to clarify the alterations of calcium-sensing receptor (CASR), a member of the G protein-coupled receptor family, in colorectal carcinogenesis. We analyzed the expression of CASR in colorectal cancer cell lines and in cancer and adenoma tissues by RT-PCR and immunostaining. In addition, we analyzed methylation of the CASR promoter by using bisulfite sequence analysis and methylation-specific PCR. CASR mRNA and protein expression was significantly downregulated in most of the cancer cell lines. CpG islands were densely methylated in cancer cell lines with reduced CASR mRNA expression. Treatment with a demethylating agent, 5-aza-2′-deoxycytidine, and/or a histone deacetylase inhibitor, trichostatin A, restored CASR expression in the cancer cell lines. Disruption of CASR expression in CASR-unmethylated HCT-8 cells blocked the enhancing effect of Ca2+ on the cytotoxic response to 5-fluorouracil. CASR expression was observed in normal colonic epithelial cells and was retained in most adenoma tissues. CASR mRNA and protein expression was significantly downregulated in cancer tissues. There was an inverse relationship between CASR expression and degree of differentiation. Immunohistochemical CASR staining was reduced more predominantly in less-differentiated cancer tissues and/or in cancer cells at the invasive front, where nuclear/cytoplasmic Β-catenin was often localized. CASR methylation was detected in 69% of colorectal cancer tissues and 90% of lymph node metastatic tissues and was significantly correlated with reduced CASR expression. CASR methylation was also detected in 32% of advanced adenoma tissues but was detected in only 9% of adenoma tissues and was not detected in hyperplastic polyp tissues. CASR methylation seems to occur at an early stage and progress in colorectal carcinogenesis. The results suggest that epigenetic inactivation of CASR has an important role in colorectal carcinogenesis.

Original languageEnglish
Pages (from-to)876-884
Number of pages9
JournalModern Pathology
Volume24
Issue number6
DOIs
Publication statusPublished - 2011 Jun
Externally publishedYes

Fingerprint

Calcium-Sensing Receptors
Epigenomics
Carcinogenesis
Methylation
Adenoma
Neoplasms
Cell Line
decitabine
Messenger RNA
Colorectal Neoplasms
trichostatin A
Down-Regulation
Catenins
Polymerase Chain Reaction
CpG Islands
Histone Deacetylase Inhibitors

Keywords

  • calcium-sensing receptor
  • chemoprevention
  • colorectal adenoma
  • colorectal carcinogenesis
  • DNA methylation

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Hizaki, K., Yamamoto, H., Taniguchi, H., Adachi, Y., Nakazawa, M., Tanuma, T., ... Shinomura, Y. (2011). Epigenetic inactivation of calcium-sensing receptor in colorectal carcinogenesis. Modern Pathology, 24(6), 876-884. https://doi.org/10.1038/modpathol.2011.10

Epigenetic inactivation of calcium-sensing receptor in colorectal carcinogenesis. / Hizaki, Keiichi; Yamamoto, Hiroyuki; Taniguchi, Hiroaki; Adachi, Yasushi; Nakazawa, Mayumi; Tanuma, Tokuma; Kato, Norihiro; Sukawa, Yasutaka; Sanchez, Jose V.; Suzuki, Hiromu; Sasaki, Shigeru; Imai, Kohzoh; Shinomura, Yasuhisa.

In: Modern Pathology, Vol. 24, No. 6, 06.2011, p. 876-884.

Research output: Contribution to journalArticle

Hizaki, K, Yamamoto, H, Taniguchi, H, Adachi, Y, Nakazawa, M, Tanuma, T, Kato, N, Sukawa, Y, Sanchez, JV, Suzuki, H, Sasaki, S, Imai, K & Shinomura, Y 2011, 'Epigenetic inactivation of calcium-sensing receptor in colorectal carcinogenesis', Modern Pathology, vol. 24, no. 6, pp. 876-884. https://doi.org/10.1038/modpathol.2011.10
Hizaki K, Yamamoto H, Taniguchi H, Adachi Y, Nakazawa M, Tanuma T et al. Epigenetic inactivation of calcium-sensing receptor in colorectal carcinogenesis. Modern Pathology. 2011 Jun;24(6):876-884. https://doi.org/10.1038/modpathol.2011.10
Hizaki, Keiichi ; Yamamoto, Hiroyuki ; Taniguchi, Hiroaki ; Adachi, Yasushi ; Nakazawa, Mayumi ; Tanuma, Tokuma ; Kato, Norihiro ; Sukawa, Yasutaka ; Sanchez, Jose V. ; Suzuki, Hiromu ; Sasaki, Shigeru ; Imai, Kohzoh ; Shinomura, Yasuhisa. / Epigenetic inactivation of calcium-sensing receptor in colorectal carcinogenesis. In: Modern Pathology. 2011 ; Vol. 24, No. 6. pp. 876-884.
@article{e1288d92df3b48f79e041df45a549ae8,
title = "Epigenetic inactivation of calcium-sensing receptor in colorectal carcinogenesis",
abstract = "Ca2+ is a chemopreventive agent for colon cancer. Ion transport systems are often altered in human cancer. The aim of this study was to clarify the alterations of calcium-sensing receptor (CASR), a member of the G protein-coupled receptor family, in colorectal carcinogenesis. We analyzed the expression of CASR in colorectal cancer cell lines and in cancer and adenoma tissues by RT-PCR and immunostaining. In addition, we analyzed methylation of the CASR promoter by using bisulfite sequence analysis and methylation-specific PCR. CASR mRNA and protein expression was significantly downregulated in most of the cancer cell lines. CpG islands were densely methylated in cancer cell lines with reduced CASR mRNA expression. Treatment with a demethylating agent, 5-aza-2′-deoxycytidine, and/or a histone deacetylase inhibitor, trichostatin A, restored CASR expression in the cancer cell lines. Disruption of CASR expression in CASR-unmethylated HCT-8 cells blocked the enhancing effect of Ca2+ on the cytotoxic response to 5-fluorouracil. CASR expression was observed in normal colonic epithelial cells and was retained in most adenoma tissues. CASR mRNA and protein expression was significantly downregulated in cancer tissues. There was an inverse relationship between CASR expression and degree of differentiation. Immunohistochemical CASR staining was reduced more predominantly in less-differentiated cancer tissues and/or in cancer cells at the invasive front, where nuclear/cytoplasmic Β-catenin was often localized. CASR methylation was detected in 69{\%} of colorectal cancer tissues and 90{\%} of lymph node metastatic tissues and was significantly correlated with reduced CASR expression. CASR methylation was also detected in 32{\%} of advanced adenoma tissues but was detected in only 9{\%} of adenoma tissues and was not detected in hyperplastic polyp tissues. CASR methylation seems to occur at an early stage and progress in colorectal carcinogenesis. The results suggest that epigenetic inactivation of CASR has an important role in colorectal carcinogenesis.",
keywords = "calcium-sensing receptor, chemoprevention, colorectal adenoma, colorectal carcinogenesis, DNA methylation",
author = "Keiichi Hizaki and Hiroyuki Yamamoto and Hiroaki Taniguchi and Yasushi Adachi and Mayumi Nakazawa and Tokuma Tanuma and Norihiro Kato and Yasutaka Sukawa and Sanchez, {Jose V.} and Hiromu Suzuki and Shigeru Sasaki and Kohzoh Imai and Yasuhisa Shinomura",
year = "2011",
month = "6",
doi = "10.1038/modpathol.2011.10",
language = "English",
volume = "24",
pages = "876--884",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Epigenetic inactivation of calcium-sensing receptor in colorectal carcinogenesis

AU - Hizaki, Keiichi

AU - Yamamoto, Hiroyuki

AU - Taniguchi, Hiroaki

AU - Adachi, Yasushi

AU - Nakazawa, Mayumi

AU - Tanuma, Tokuma

AU - Kato, Norihiro

AU - Sukawa, Yasutaka

AU - Sanchez, Jose V.

AU - Suzuki, Hiromu

AU - Sasaki, Shigeru

AU - Imai, Kohzoh

AU - Shinomura, Yasuhisa

PY - 2011/6

Y1 - 2011/6

N2 - Ca2+ is a chemopreventive agent for colon cancer. Ion transport systems are often altered in human cancer. The aim of this study was to clarify the alterations of calcium-sensing receptor (CASR), a member of the G protein-coupled receptor family, in colorectal carcinogenesis. We analyzed the expression of CASR in colorectal cancer cell lines and in cancer and adenoma tissues by RT-PCR and immunostaining. In addition, we analyzed methylation of the CASR promoter by using bisulfite sequence analysis and methylation-specific PCR. CASR mRNA and protein expression was significantly downregulated in most of the cancer cell lines. CpG islands were densely methylated in cancer cell lines with reduced CASR mRNA expression. Treatment with a demethylating agent, 5-aza-2′-deoxycytidine, and/or a histone deacetylase inhibitor, trichostatin A, restored CASR expression in the cancer cell lines. Disruption of CASR expression in CASR-unmethylated HCT-8 cells blocked the enhancing effect of Ca2+ on the cytotoxic response to 5-fluorouracil. CASR expression was observed in normal colonic epithelial cells and was retained in most adenoma tissues. CASR mRNA and protein expression was significantly downregulated in cancer tissues. There was an inverse relationship between CASR expression and degree of differentiation. Immunohistochemical CASR staining was reduced more predominantly in less-differentiated cancer tissues and/or in cancer cells at the invasive front, where nuclear/cytoplasmic Β-catenin was often localized. CASR methylation was detected in 69% of colorectal cancer tissues and 90% of lymph node metastatic tissues and was significantly correlated with reduced CASR expression. CASR methylation was also detected in 32% of advanced adenoma tissues but was detected in only 9% of adenoma tissues and was not detected in hyperplastic polyp tissues. CASR methylation seems to occur at an early stage and progress in colorectal carcinogenesis. The results suggest that epigenetic inactivation of CASR has an important role in colorectal carcinogenesis.

AB - Ca2+ is a chemopreventive agent for colon cancer. Ion transport systems are often altered in human cancer. The aim of this study was to clarify the alterations of calcium-sensing receptor (CASR), a member of the G protein-coupled receptor family, in colorectal carcinogenesis. We analyzed the expression of CASR in colorectal cancer cell lines and in cancer and adenoma tissues by RT-PCR and immunostaining. In addition, we analyzed methylation of the CASR promoter by using bisulfite sequence analysis and methylation-specific PCR. CASR mRNA and protein expression was significantly downregulated in most of the cancer cell lines. CpG islands were densely methylated in cancer cell lines with reduced CASR mRNA expression. Treatment with a demethylating agent, 5-aza-2′-deoxycytidine, and/or a histone deacetylase inhibitor, trichostatin A, restored CASR expression in the cancer cell lines. Disruption of CASR expression in CASR-unmethylated HCT-8 cells blocked the enhancing effect of Ca2+ on the cytotoxic response to 5-fluorouracil. CASR expression was observed in normal colonic epithelial cells and was retained in most adenoma tissues. CASR mRNA and protein expression was significantly downregulated in cancer tissues. There was an inverse relationship between CASR expression and degree of differentiation. Immunohistochemical CASR staining was reduced more predominantly in less-differentiated cancer tissues and/or in cancer cells at the invasive front, where nuclear/cytoplasmic Β-catenin was often localized. CASR methylation was detected in 69% of colorectal cancer tissues and 90% of lymph node metastatic tissues and was significantly correlated with reduced CASR expression. CASR methylation was also detected in 32% of advanced adenoma tissues but was detected in only 9% of adenoma tissues and was not detected in hyperplastic polyp tissues. CASR methylation seems to occur at an early stage and progress in colorectal carcinogenesis. The results suggest that epigenetic inactivation of CASR has an important role in colorectal carcinogenesis.

KW - calcium-sensing receptor

KW - chemoprevention

KW - colorectal adenoma

KW - colorectal carcinogenesis

KW - DNA methylation

UR - http://www.scopus.com/inward/record.url?scp=79957904432&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957904432&partnerID=8YFLogxK

U2 - 10.1038/modpathol.2011.10

DO - 10.1038/modpathol.2011.10

M3 - Article

C2 - 21317879

AN - SCOPUS:79957904432

VL - 24

SP - 876

EP - 884

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 6

ER -